Overview

Gender

male

Investor Type

Investment Partner

Sanford Zweifach is the Chairman of the board of directors of Palladio Biosciences.

Sandy brings to Palladio over 25 years’ experience in senior executive roles in the life sciences industry, with a focus in corporate partnering, business development, operations, private and public investing, and capital raising. He is the co-founder and chief executive officer of Nuvelution Pharma. Previously, Zweifach was the Co-founder and CEO of Ascendancy Healthcare. He has also been a Partner at Reedland Capital Partners, CEO of Pathways Diagnostics, Managing Director and CFO of Bay City Capital, and President and CFO of Epoch Biosciences, which was acquired by Nanogen.

Sandy currently serves as the Chair of IMIDomics SL and non-executive board member of Compugen and Realm Therapeutics. He received his BA in Biology from UC San Diego and an MS in Human Physiology from UC Davis.